- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Telangana issues advisory on prescription medicines sales in Telangana

Telangana: The Drugs Control Administration, Telangana, has issued an advisory to all retail and wholesale medical shops as well as general public, following concerns over the indiscriminate sale of prescription medicines, including habit-forming drugs, within the state.
The DCA has expressed alarm over the indiscriminate sale of prescription medications, which is putting public health at significant risk.
In view of the health risks associated with unsupervised use, certain medicines are classified under Schedule H of the Drugs Rules. Additionally, due to their high potential for abuse and dependence, habit-forming drugs are classified under Schedule H1 and Schedule X of the Drugs Rules. Medicines included under these schedules are subject to stringent regulatory controls and can be sold only by licensed retail pharmacies against a valid prescription issued by a Registered Medical Practitioner. Maintenance of the prescribed records and registers for such drugs is mandatorily required under the Drugs Rules.
The abuse of habit-forming drugs and other prescription medicines, such as Mephentermine injections and Atracurium Besylate injections, can lead to severe health consequences. Continued misuse or overdose may result in respiratory depression, coma, and, in extreme cases, death.
The administration has reminded and reiterated to all licensees that Schedule H, Schedule H1, and Schedule X drugs shall mandatorily be sold only against a valid prescription issued by a Registered Medical Practitioner.
Any illegal sale, diversion, or distribution of such prescription medicines for nontherapeutic or abusive purposes constitutes a serious violation of the provisions of the Drugs and Cosmetics Act, 1940 and the Rules thereunder, and shall be dealt with strictly. DCA, Telangana shall initiate stringent actions, including cancellation of drug licences and prosecution under the relevant provisions of the Drugs and Cosmetics Act, 1940, Telangana DCA stated.
The DCA has advised all medical shops to exercise utmost vigilance in dispensing such medicines and to maintain proper prescription records as mandated under the Rules.
The strict compliance of all stakeholders is mandatorily required to ensure that these prescription medicines are not diverted for misuse and that public health and safety are effectively safeguarded.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

